Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
Biomolecules · 31.01.2024 · 14 (2) · 171
DOI: 10.3390/biom14020171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 31.01.2024. Verfasst von Agata Mlynska und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Institute, LT-08406 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Melanoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, European Social Fund.
Abstract (Originalsprache)
The spatial distribution of tumor infiltrating lymphocytes (TILs) defines several histologically and clinically distinct immune subtypes—desert (no TILs), excluded (TILs in stroma), and inflamed (TILs in tumor parenchyma). To date, robust classification of immune subtypes still requires deeper experimental evidence across various cancer types. Here, we aimed to investigate, define, and validate the immune subtypes in melanoma by coupling transcriptional and histological assessments of the lymphocyte distribution in tumor parenchyma and stroma. We used the transcriptomic data from The Cancer Genome Atlas melanoma dataset to screen for the desert, excluded, and inflamed immune subtypes. We defined subtype-specific genes and used them to construct a subtype assignment algorithm. We validated the two-step algorithm in the qPCR data of real-world melanoma tumors with histologically defined immune subtypes. The accuracy of a classifier encompassing expression data of seven genes (immune response-related: CD2, CD53, IRF1, and CD8B; and stroma-related: COL5A2, TNFAIP6, and INHBA) in a validation cohort reached 79%. Our findings suggest that melanoma tumors can be classified into transcriptionally and histologically distinct desert, excluded, and inflamed subtypes. Gene expression-based algorithms can assist physicians and pathologists as biomarkers in the rapid assessment of a tumor immune microenvironment while serving as a tool for clinical decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Cancer Institute, LT-08406 Vilnius, Lithuania.
- Faculty of Fundamental Sciences, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.
- Life Sciences Center, Vilnius University, LT-01513 Vilnius, Lithuania.
- National Center of Pathology, LT-08406 Vilnius, Lithuania.
ORCID-Profile: Agata Mlynska, Julija Mažeikaitė, Ieva Kerševičiūtė, Vygantė Maskoliūnaitė, Rasa Sabaliauskaitė
Förderung
- European Union
- European Social Fund
Zitieren
APA
Mlynska, A., Gibavičienė, J., Kutanovaitė, O., Senkus, L., Mažeikaitė, J., Kerševičiūtė, I., Maskoliūnaitė, V., Rupeikaitė, N., Sabaliauskaitė, R., Gaiževska, J., Suveizdė, K., Kraśko, J. A., Dobrovolskienė, N., Paberalė, E., Žymantaitė, E., & Pašukonienė, V. (2024). Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns. Biomolecules, 14(2), 171. https://doi.org/10.3390/biom14020171
Vancouver
Mlynska A, Gibavičienė J, Kutanovaitė O, Senkus L, Mažeikaitė J, Kerševičiūtė I, et al. Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns. Biomolecules. 2024;14(2):171. doi:10.3390/biom14020171
BibTeX
@article{Mlynska2024,
author = {Mlynska, Agata and Gibavičienė, Jolita and Kutanovaitė, Otilija and Senkus, Linas and Mažeikaitė, Julija and Kerševičiūtė, Ieva and Maskoliūnaitė, Vygantė and Rupeikaitė, Neda and Sabaliauskaitė, Rasa and Gaiževska, Justina and Suveizdė, Karolina and Kraśko, Jan Aleksander and Dobrovolskienė, Neringa and Paberalė, Emilija and Žymantaitė, Eglė and Pašukonienė, Vita},
title = {Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {2},
pages = {171},
doi = {10.3390/biom14020171}
}
EUVIMED